Literature DB >> 34514510

Will mastering ferroptosis allow treating refractory meningiomas?

Christine Marosi1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34514510      PMCID： PMC8643476          DOI： 10.1093/neuonc/noab218

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  9 in total

Review 1.  Metabolic networks in ferroptosis.

Authors:  Shihui Hao; Bishan Liang; Qiong Huang; Shumin Dong; Zhenzhen Wu; Wanming He; Min Shi
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

2.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

3.  Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

Authors:  Matthias Preusser; Antonio Silvani; Emilie Le Rhun; Riccardo Soffietti; Giuseppe Lombardi; Juan Manuel Sepulveda; Petter Brandal; Lucy Brazil; Alice Bonneville-Levard; Veronique Lorgis; Elodie Vauleon; Jacoline Bromberg; Sara Erridge; Alison Cameron; Florence Lefranc; Paul M Clement; Sarah Dumont; Marc Sanson; Charlotte Bronnimann; Carmen Balaná; Niklas Thon; Joanne Lewis; Maximilian J Mair; Philipp Sievers; Julia Furtner; Josef Pichler; Jordi Bruna; Francois Ducray; Jaap C Reijneveld; Christian Mawrin; Martin Bendszus; Christine Marosi; Vassilis Golfinopoulos; Corneel Coens; Thierry Gorlia; Michael Weller; Felix Sahm; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  Regulation of ferroptotic cancer cell death by GPX4.

Authors:  Wan Seok Yang; Rohitha SriRamaratnam; Matthew E Welsch; Kenichi Shimada; Rachid Skouta; Vasanthi S Viswanathan; Jaime H Cheah; Paul A Clemons; Alykhan F Shamji; Clary B Clish; Lewis M Brown; Albert W Girotti; Virginia W Cornish; Stuart L Schreiber; Brent R Stockwell
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

5.  Systemic therapy for recurrent meningioma.

Authors:  E Le Rhun; S Taillibert; M C Chamberlain
Journal:  Expert Rev Neurother       Date:  2016-05-19       Impact factor: 4.618

Review 6.  Ferroptosis: mechanisms, biology and role in disease.

Authors:  Xuejun Jiang; Brent R Stockwell; Marcus Conrad
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-25       Impact factor: 94.444

7.  Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.

Authors:  Hiroyuki Takeda; Masashi Okada; Kenta Kuramoto; Shuhei Suzuki; Hirotsugu Sakaki; Tomomi Sanomachi; Shizuka Seino; Takashi Yoshioka; Hirofumi Hirano; Kazunori Arita; Chifumi Kitanaka
Journal:  Oncotarget       Date:  2017-06-29

8.  Gemcitabine in Recurrent Meningioma.

Authors:  Satvik Khaddar; Arti Bhelekar; Ochin Dale; Litty Varghese; Vijay Maruti Patil
Journal:  South Asian J Cancer       Date:  2021-06-15

Review 9.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029
  9 in total
  1 in total

Review 1.  Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction.

Authors:  Marc Dahlmanns; Eduard Yakubov; Jana Katharina Dahlmanns
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.